Literature DB >> 24703771

N-Cadherin and Tie2 positive CD34⁺CD38⁻CD123⁺ leukemic stem cell populations can develop acute myeloid leukemia more effectively in NOD/SCID mice.

Shaowei Qiu1, Yujiao Jia1, Haiyan Xing1, Tengteng Yu1, Jing Yu1, Pei Yu1, Kejing Tang1, Zheng Tian1, Huijun Wang1, Yingchang Mi1, Qing Rao1, Min Wang1, Jianxiang Wang2.   

Abstract

Emerging studies suggest that the population of malignant cells found in human acute myelogenous leukemia (AML) arises from a rare population of leukemic stem cells (LSCs). A lot of investigators have reported the identification of cell surface markers, such as CD123. Here, we report the identification of N-cadherin and Tie2 as LSCs markers. Inoculation of CD34(+)CD38(-)CD123(+)N-cadherin(+) and CD34(+)CD38(-)CD123(+) Tie2(+) population can induce leukemia in NOD/SCID mice. The leukemic blast cells from the primary leukemic mice could also induce leukemia in the secondary transplantation. These findings suggested that N-cadherin and Tie2 were the important markers that can assist in leukemia development.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute myeloid leukemia; Leukemic stem cell; N-Cadherin; Tie2

Mesh:

Substances:

Year:  2014        PMID: 24703771     DOI: 10.1016/j.leukres.2014.03.007

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  12 in total

Review 1.  Tie-1: A potential target for anti-angiogenesis therapy.

Authors:  Ping Yang; Na Chen; Jing-Hui Jia; Xue-Jiao Gao; Shi-Han Li; Jing Cai; Zehua Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

Review 2.  Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.

Authors:  Sonali P Barwe; Anthony Quagliano; Anilkumar Gopalakrishnapillai
Journal:  Semin Oncol       Date:  2017-07-11       Impact factor: 4.929

Review 3.  Cancer stem cells and nanotechnological approaches for eradication.

Authors:  Gholam Basati; Mojtaba Khaksarian; Saber Abbaszadeh; Hamed Esmaeil Lashgarian; Abdolrazagh Marzban
Journal:  Stem Cell Investig       Date:  2019-11-28

4.  Normal hematopoiesis and lack of β-catenin activation in osteoblasts of patients and mice harboring Lrp5 gain-of-function mutations.

Authors:  Marta Galán-Díez; Adiba Isa; Marco Ponzetti; Morten Frost Nielsen; Moustapha Kassem; Stavroula Kousteni
Journal:  Biochim Biophys Acta       Date:  2015-12-08

5.  Characteristics of doxorubicin-selected multidrug-resistant human leukemia HL-60 cells with tolerance to arsenic trioxide and contribution of leukemia stem cells.

Authors:  Jing Chen; Hulai Wei; Jie Cheng; Bei Xie; Bei Wang; Juan Yi; Baoying Tian; Zhuan Liu; Feifei Wang; Zhewen Zhang
Journal:  Oncol Lett       Date:  2017-11-06       Impact factor: 2.967

6.  JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signaling.

Authors:  Yaping Zhang; Fangzhen Xia; Xiaoye Liu; Zhuo Yu; Li Xie; Ligen Liu; Chiqi Chen; Haishan Jiang; Xiaoxin Hao; Xiaoxiao He; Feifei Zhang; Hao Gu; Jun Zhu; Haitao Bai; Cheng Cheng Zhang; Guo-Qiang Chen; Junke Zheng
Journal:  J Clin Invest       Date:  2018-03-26       Impact factor: 14.808

7.  Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherin.

Authors:  K D Marjon; C M Termini; K L Karlen; C Saito-Reis; C E Soria; K A Lidke; J M Gillette
Journal:  Oncogene       Date:  2015-11-23       Impact factor: 9.867

8.  Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.

Authors:  Adhra Al-Mawali; David Gillis; Ian Lewis
Journal:  J Hematol Oncol       Date:  2016-07-27       Impact factor: 17.388

9.  Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts.

Authors:  M Cartellieri; A Feldmann; S Koristka; C Arndt; S Loff; A Ehninger; M von Bonin; E P Bejestani; G Ehninger; M P Bachmann
Journal:  Blood Cancer J       Date:  2016-08-12       Impact factor: 11.037

Review 10.  N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer.

Authors:  Krzysztof Marek Mrozik; Orest William Blaschuk; Chee Man Cheong; Andrew Christopher William Zannettino; Kate Vandyke
Journal:  BMC Cancer       Date:  2018-10-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.